- Home
- FHN vs RZLT Comparison
FHN vs RZLT Comparison
Compare FHN & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHN
- RZLT
- Stock Information
- Founded
- FHN 1864
- RZLT 2010
- Country
- FHN United States
- RZLT United States
- Employees
- FHN 7200
- RZLT N/A
- Industry
- FHN Major Banks
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- FHN Finance
- RZLT Health Care
- Exchange
- FHN Nasdaq
- RZLT Nasdaq
- Market Cap
- FHN 10.7B
- RZLT 361.3M
- IPO Year
- FHN N/A
- RZLT N/A
- Fundamental
- Price
- FHN $21.72
- RZLT $4.82
- Analyst Decision
- FHN Buy
- RZLT Strong Buy
- Analyst Count
- FHN 17
- RZLT 6
- Target Price
- FHN $22.26
- RZLT $12.00
- AVG Volume (30 Days)
- FHN 5.9M
- RZLT 1.4M
- Earning Date
- FHN 07-16-2025
- RZLT 05-13-2025
- Dividend Yield
- FHN 2.73%
- RZLT N/A
- EPS Growth
- FHN N/A
- RZLT N/A
- EPS
- FHN 1.44
- RZLT N/A
- Revenue
- FHN $3,043,000,000.00
- RZLT N/A
- Revenue This Year
- FHN $11.15
- RZLT $35.39
- Revenue Next Year
- FHN $3.91
- RZLT N/A
- P/E Ratio
- FHN $15.30
- RZLT N/A
- Revenue Growth
- FHN 3.43
- RZLT N/A
- 52 Week Low
- FHN $14.34
- RZLT $2.22
- 52 Week High
- FHN $22.44
- RZLT $6.19
- Technical
- Relative Strength Index (RSI)
- FHN 74.09
- RZLT 67.57
- Support Level
- FHN $20.98
- RZLT $4.15
- Resistance Level
- FHN $20.62
- RZLT $4.71
- Average True Range (ATR)
- FHN 0.41
- RZLT 0.27
- MACD
- FHN 0.19
- RZLT 0.04
- Stochastic Oscillator
- FHN 95.35
- RZLT 89.36
About FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.